+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Kidney Cancer Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 93 Pages
  • February 2024
  • Region: Global
  • Prof Research
  • ID: 5728639
Description Jump to:
This report describes the global market size of Kidney Cancer Drugs from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.

This report covers the following regions:

  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players as well as some small players.

The information for each competitor includes:

  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment:

  • Renal cell carcinoma
  • Transitional cell carcinoma

Companies Covered:

  • Bayer
  • Bristol-Myers Squibb
  • Eisai
  • Exelixis
  • Genentech (Roche)
  • Novartis
  • Pfizer
  • Prometheus Labs
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Kidney Cancer Drugs Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Kidney Cancer Drugs Market in North America (2019-2029)
8.1 Kidney Cancer Drugs Market Size
8.2 Kidney Cancer Drugs Market by End Use
8.3 Competition by Players/Suppliers
8.4 Kidney Cancer Drugs Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Kidney Cancer Drugs Market in South America (2019-2029)
9.1 Kidney Cancer Drugs Market Size
9.2 Kidney Cancer Drugs Market by End Use
9.3 Competition by Players/Suppliers
9.4 Kidney Cancer Drugs Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Kidney Cancer Drugs Market in Asia & Pacific (2019-2029)
10.1 Kidney Cancer Drugs Market Size
10.2 Kidney Cancer Drugs Market by End Use
10.3 Competition by Players/Suppliers
10.4 Kidney Cancer Drugs Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Kidney Cancer Drugs Market in Europe (2019-2029)
11.1 Kidney Cancer Drugs Market Size
11.2 Kidney Cancer Drugs Market by End Use
11.3 Competition by Players/Suppliers
11.4 Kidney Cancer Drugs Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Kidney Cancer Drugs Market in MEA (2019-2029)
12.1 Kidney Cancer Drugs Market Size
12.2 Kidney Cancer Drugs Market by End Use
12.3 Competition by Players/Suppliers
12.4 Kidney Cancer Drugs Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Kidney Cancer Drugs Market (2019-2024)
13.1 Kidney Cancer Drugs Market Size
13.2 Kidney Cancer Drugs Market by End Use
13.3 Competition by Players/Suppliers
13.4 Kidney Cancer Drugs Market Size by Type
Chapter 14 Global Kidney Cancer Drugs Market Forecast (2024-2029)
14.1 Kidney Cancer Drugs Market Size Forecast
14.2 Kidney Cancer Drugs Application Forecast
14.3 Competition by Players/Suppliers
14.4 Kidney Cancer Drugs Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Bayer
15.1.1 Company Profile
15.1.2 Main Business and Kidney Cancer Drugs Information
15.1.3 SWOT Analysis of Bayer
215.1.4 Bayer Kidney Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.2 Bristol-Myers Squibb
15.2.1 Company Profile
15.2.2 Main Business and Kidney Cancer Drugs Information
15.2.3 SWOT Analysis of Bristol-Myers Squibb
215.2.4 Bristol-Myers Squibb Kidney Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.3 Eisai
15.3.1 Company Profile
15.3.2 Main Business and Kidney Cancer Drugs Information
15.3.3 SWOT Analysis of Eisai
215.3.4 Eisai Kidney Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.4 Exelixis
15.4.1 Company Profile
15.4.2 Main Business and Kidney Cancer Drugs Information
15.4.3 SWOT Analysis of Exelixis
215.4.4 Exelixis Kidney Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.5 Genentech (Roche)
15.5.1 Company Profile
15.5.2 Main Business and Kidney Cancer Drugs Information
15.5.3 SWOT Analysis of Genentech (Roche)
215.5.4 Genentech (Roche) Kidney Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.6 Novartis
15.6.1 Company Profile
15.6.2 Main Business and Kidney Cancer Drugs Information
15.6.3 SWOT Analysis of Novartis
215.6.4 Novartis Kidney Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.7 Pfizer
15.7.1 Company Profile
15.7.2 Main Business and Kidney Cancer Drugs Information
15.7.3 SWOT Analysis of Pfizer
215.7.4 Pfizer Kidney Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
15.8 Prometheus Labs
15.8.1 Company Profile
15.8.2 Main Business and Kidney Cancer Drugs Information
15.8.3 SWOT Analysis of Prometheus Labs
215.8.4 Prometheus Labs Kidney Cancer Drugs Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Kidney Cancer Drugs Report
Table Data Sources of Kidney Cancer Drugs Report
Table Major Assumptions of Kidney Cancer Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Kidney Cancer Drugs Picture
Table Kidney Cancer Drugs Classification
Table Kidney Cancer Drugs Applications
Table Drivers of Kidney Cancer Drugs Market
Table Restraints of Kidney Cancer Drugs Market
Table Opportunities of Kidney Cancer Drugs Market
Table Threats of Kidney Cancer Drugs Market
Table COVID-19 Impact For Kidney Cancer Drugs Market
Table Raw Materials Suppliers
Table Different Production Methods of Kidney Cancer Drugs
Table Cost Structure Analysis of Kidney Cancer Drugs
Table Key End Users
Table Latest News of Kidney Cancer Drugs Market
Table Merger and Acquisition
Table Planned/Future Project of Kidney Cancer Drugs Market
Table Policy of Kidney Cancer Drugs Market
Table 2019-2029 North America Kidney Cancer Drugs Market Size
Figure 2019-2029 North America Kidney Cancer Drugs Market Size and CAGR
Table 2019-2029 North America Kidney Cancer Drugs Market Size by Application
Table 2019-2024 North America Kidney Cancer Drugs Key Players Revenue
Table 2019-2024 North America Kidney Cancer Drugs Key Players Market Share
Table 2019-2029 North America Kidney Cancer Drugs Market Size by Type
Table 2019-2029 United States Kidney Cancer Drugs Market Size
Table 2019-2029 Canada Kidney Cancer Drugs Market Size
Table 2019-2029 Mexico Kidney Cancer Drugs Market Size
Table 2019-2029 South America Kidney Cancer Drugs Market Size
Figure 2019-2029 South America Kidney Cancer Drugs Market Size and CAGR
Table 2019-2029 South America Kidney Cancer Drugs Market Size by Application
Table 2019-2024 South America Kidney Cancer Drugs Key Players Revenue
Table 2019-2024 South America Kidney Cancer Drugs Key Players Market Share
Table 2019-2029 South America Kidney Cancer Drugs Market Size by Type
Table 2019-2029 Brazil Kidney Cancer Drugs Market Size
Table 2019-2029 Argentina Kidney Cancer Drugs Market Size
Table 2019-2029 Chile Kidney Cancer Drugs Market Size
Table 2019-2029 Peru Kidney Cancer Drugs Market Size
Table 2019-2029 Asia & Pacific Kidney Cancer Drugs Market Size
Figure 2019-2029 Asia & Pacific Kidney Cancer Drugs Market Size and CAGR
Table 2019-2029 Asia & Pacific Kidney Cancer Drugs Market Size by Application
Table 2019-2024 Asia & Pacific Kidney Cancer Drugs Key Players Revenue
Table 2019-2024 Asia & Pacific Kidney Cancer Drugs Key Players Market Share
Table 2019-2029 Asia & Pacific Kidney Cancer Drugs Market Size by Type
Table 2019-2029 China Kidney Cancer Drugs Market Size
Table 2019-2029 India Kidney Cancer Drugs Market Size
Table 2019-2029 Japan Kidney Cancer Drugs Market Size
Table 2019-2029 South Korea Kidney Cancer Drugs Market Size
Table 2019-2029 Southeast Asia Kidney Cancer Drugs Market Size
Table 2019-2029 Australia Kidney Cancer Drugs Market Size
Table 2019-2029 Europe Kidney Cancer Drugs Market Size
Figure 2019-2029 Europe Kidney Cancer Drugs Market Size and CAGR
Table 2019-2029 Europe Kidney Cancer Drugs Market Size by Application
Table 2019-2024 Europe Kidney Cancer Drugs Key Players Revenue
Table 2019-2024 Europe Kidney Cancer Drugs Key Players Market Share
Table 2019-2029 Europe Kidney Cancer Drugs Market Size by Type
Table 2019-2029 Germany Kidney Cancer Drugs Market Size
Table 2019-2029 France Kidney Cancer Drugs Market Size
Table 2019-2029 United Kingdom Kidney Cancer Drugs Market Size
Table 2019-2029 Italy Kidney Cancer Drugs Market Size
Table 2019-2029 Spain Kidney Cancer Drugs Market Size
Table 2019-2029 Belgium Kidney Cancer Drugs Market Size
Table 2019-2029 Netherlands Kidney Cancer Drugs Market Size
Table 2019-2029 Austria Kidney Cancer Drugs Market Size
Table 2019-2029 Poland Kidney Cancer Drugs Market Size
Table 2019-2029 Russia Kidney Cancer Drugs Market Size
Table 2019-2029 MEA Kidney Cancer Drugs Market Size
Figure 2019-2029 MEA Kidney Cancer Drugs Market Size and CAGR
Table 2019-2029 MEA Kidney Cancer Drugs Market Size by Application
Table 2019-2024 MEA Kidney Cancer Drugs Key Players Revenue
Table 2019-2024 MEA Kidney Cancer Drugs Key Players Market Share
Table 2019-2029 MEA Kidney Cancer Drugs Market Size by Type
Table 2019-2029 Egypt Kidney Cancer Drugs Market Size
Table 2019-2029 Israel Kidney Cancer Drugs Market Size
Table 2019-2029 South Africa Kidney Cancer Drugs Market Size
Table 2019-2029 Gulf Cooperation Council Countries Kidney Cancer Drugs Market Size
Table 2019-2029 Turkey Kidney Cancer Drugs Market Size
Table 2019-2024 Global Kidney Cancer Drugs Market Size by Region
Table 2019-2024 Global Kidney Cancer Drugs Market Size Share by Region
Table 2019-2024 Global Kidney Cancer Drugs Market Size by Application
Table 2019-2024 Global Kidney Cancer Drugs Market Share by Application
Table 2019-2024 Global Kidney Cancer Drugs Key Vendors Revenue
Figure 2019-2024 Global Kidney Cancer Drugs Market Size and Growth Rate
Table 2019-2024 Global Kidney Cancer Drugs Key Vendors Market Share
Table 2019-2024 Global Kidney Cancer Drugs Market Size by Type
Table 2019-2024 Global Kidney Cancer Drugs Market Share by Type
Table 2024-2029 Global Kidney Cancer Drugs Market Size by Region
Table 2024-2029 Global Kidney Cancer Drugs Market Size Share by Region
Table 2024-2029 Global Kidney Cancer Drugs Market Size by Application
Table 2024-2029 Global Kidney Cancer Drugs Market Share by Application
Table 2024-2029 Global Kidney Cancer Drugs Key Vendors Revenue
Figure 2024-2029 Global Kidney Cancer Drugs Market Size and Growth Rate
Table 2024-2029 Global Kidney Cancer Drugs Key Vendors Market Share
Table 2024-2029 Global Kidney Cancer Drugs Market Size by Type
Table 2024-2029 Kidney Cancer Drugs Global Market Share by Type

Companies Mentioned

  • Bayer
  • Bristol-Myers Squibb
  • Eisai
  • Exelixis
  • Genentech (Roche)
  • Novartis
  • Pfizer
  • Prometheus Labs

Related Topics

Related Reports

Kidney Cancer Drugs Market - Global Forecast 2025-2032 - Product Image

Kidney Cancer Drugs Market - Global Forecast 2025-2032

  • Report
  • 182 Pages
  • Global
From
Kidney Cancer Therapeutics and Diagnostics - Global Strategic Business Report - Product Image

Kidney Cancer Therapeutics and Diagnostics - Global Strategic Business Report

  • Report
  • 299 Pages
  • Global
From
Kidney Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Kidney Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Kidney Cancer Drugs Market Report 2025 - Product Image

Kidney Cancer Drugs Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Kidney Cancer Diagnostics and Therapeutics Market Report 2025 - Product Image

Kidney Cancer Diagnostics and Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.